BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 12579103)

  • 21. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of endothelial and coagulation systems in left ventricular assist device recipients.
    John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R
    Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
    Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
    J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation].
    Gaudino M; Nasso G; Zamparelli R; Andreotti F; Burzotta F; Iacoviello L; Santarelli F; Lapenna E; Bruno P; Di Pietrantonio F; Schiavello R; Maseri A; Possati G
    Ital Heart J Suppl; 2002 Jun; 3(6):646-51. PubMed ID: 12116815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass.
    Chandler WL
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):459-67. PubMed ID: 16085250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
    Becker RC; Alexander JH; Newby LK; Yang H; Barrett Y; Mohan P; Wang J; Harrington RA; Wallentin LC
    Thromb Haemost; 2010 Nov; 104(5):976-83. PubMed ID: 20806117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombogenic mechanisms in the human: fresh insights obtained by immunodiagnostic studies of coagulation markers.
    Boisclair MD; Philippou H; Lane DA
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1007-21. PubMed ID: 8148474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
    Bailey MA; Griffin KJ; Sohrabi S; Whalley DJ; Johnson AB; Baxter PD; Ariëns RA; Scott DJ
    J Vasc Surg; 2013 Jun; 57(6):1512-8. PubMed ID: 23490299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation].
    Shinohara M; Kurokawa H; Yoshihara Y; Kokubu S; Kusano T; Horie K; Murakami N; Nagai K; Nara N
    Rinsho Byori; 1997 Feb; 45(2):179-84. PubMed ID: 9121003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty.
    Borris LC; Breindahl M; Ryge C; Sommer HM; Lassen MR;
    Thromb Res; 2007; 121(3):369-76. PubMed ID: 17599394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
    Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifications of coagulation and fibrinolytic parameters in laparoscopic cholecystectomy.
    Vecchio R; Cacciola E; Martino M; Cacciola RR; MacFadyen BV
    Surg Endosc; 2003 Mar; 17(3):428-33. PubMed ID: 12457211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic fibrinogen infusion in cardiac surgery patients: effects on biomarkers of coagulation, fibrinolysis, and platelet function.
    Karlsson M; Ternström L; Hyllner M; Baghaei F; Skrtic S; Jeppsson A
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):396-404. PubMed ID: 20530054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
    Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
    Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.